All News

Although GLP-1 receptor agonists have shown promise in promoting weight loss, they are prescription medications and should be used under the guidance of health care professionals.

The CDK12/13 inhibitor will be tested for efficacy and safety in patients with advanced solid tumors, such as breast, ovarian, and Ewing Sarcoma.

Precision medicine in pharmacy has the potential to revolutionize patient care by optimizing drug selection, dosing, and monitoring.

Hypercortisolemia during the late afternoon and early evening is harmful and believed to cause insulin resistance observed with advanced age.

Research into the mechanisms of intravenous immunoglobulin is often challenging due to the complexity of polyclonal preparations, including diversity, repertoires, blocking, or anti-idiotypic antibodies.

A low dose of the combination treatment inhibited AML cell cycle and increased apoptosis.

Researchers have identified new uses for insulin sensitizers, including in the treatment of polycystic ovary syndrome and infertility.

Although findings indicate a relationship between vitamin D and mood disorders, further research is needed to clarify efficacy of specific vitamin D levels, as well as supplement dose and form.

With pharmacies around the country shifting to provide more comprehensive care and becoming true health care destinations, Chichi Ilonzo Momah, PharmD, RPh said she is excited for the future of the field.

Pharmacists can make clinical recommendations tailored to patients’ individual needs.

Applying novel and effective behavioral economics for pre-exposure prophylaxis dissemination programs could help to tailor the programs to the populations and settings of high HIV burden areas.

A phase 3 study assessing macitentan 75mg treatment for CTEPH was stopped, although another study using macitentan will continue.

In addition to improving risk evaluation in older adults at home, point-of-care testing may help clinicians manage patients with dementia who cannot communicate and those living in depopulated areas.

Harsha Rajasimha, PhD, MS, founder and CEO of Jeeva Informatics Solutions, discusses the importance of representation of women and minority groups in clinical trials.

Although it has some daunting adverse effects, Glenn Short, PhD, said ibogaine offers unique biological and therapeutic effects.

Correctly diagnosing specific follicular lymphomas and marginal zone lymphomas requires knowledge of the clinical context, including the site of involvement, age, and clinical presentation.

Using metagenomic information, the technology isolates phages whose enzymes can specifically target the bacteria that causes C. difficile infection.

Multiple studies show that it might be more effective to administer intravenous immunoglobulins at an earlier stage of disease progression.

Investigators must find a different combination or treatment regimen using a dual blockade of the PARP and PI3K/AKT/mTOR pathway.

Incorporate Program Requirements Into Systems and Workflows.

With the emergence of BA.2.86, and the growing prevalence of EG.5 and FL1.5.1, there is a need for updated vaccines against COVID-19 to help decrease severe disease and hospitalizations.

Patients who received amivantamab plus chemotherapy or amivantamab without chemotherapy presented better outcomes compared to chemotherapy alone.

Beyond its primary role in diabetes treatment, SGLT-2 inhibitors have demonstrated versatility in various health aspects, offering benefits beyond glucose reduction.

With new vaccines expected for both SARS-CoV-2 and influenza, educate patients on the ongoing need for immunizations

Black women had the highest rates of obesity-related cardiovascular disease deaths whereas other racial groups had more men experiencing obesity-related CVD deaths than women.

The importance of findability, accessibility, interoperability, and reusability has become even more significant to academics as government agencies increasingly require data openness and accessibility for funding eligibility.

Christina Madison, PharmD, FCCP, AAHIVP, speaks with Ryan Haumschild, PharmD, MS, MBA, to discuss current issues in oncology, including drug shortages and patient access.